Molecular You | Preventive Medicine

Traditionally medicine has had difficulty in identifying people at risk of developing a disease or in the very early stages of disease. A comprehensive innovative approach designed to detect early signs of potential disease would allow early stage intervention before serious consequences occur.     Opportunity   The emergence of low-cost Omic analysis makes it possible to now analyse an individual at the molecular level affordably. Integrating individual Omic ...

GenXys | Application of Pharmacogenomics in Primary Care

Opportunity   Family physicians and other health care providers face difficult decisions when they try to predict whether a patient will benefit from a newly prescribed medication or whether they will experience harmful effects. Genetic tests can inform the probability of harm or benefit of some medications; however there is currently no way of incorporating this genetic information into routine family practice ...

iTARGET Autism

Earlier and more accurate diagnoses of ASDs will help patients and their families manage the disorders with the best possible results. iTARGET Autism aims to guide an individualized approach to the detection, management and treatment that is more effective than the currently available methods.     Opportunity   The Autism Spectrum Disorders (ASDs) are defined by significant challenges with communication, social reciprocity, and structured ...

Biomarkers for Precise Prescribing for Diabetic Patients

As of 2014, 387 million people worldwide suffer from diabetes at a stunning cost of over $450 billion for medical care. The disease is complex and caused by various factors that influence each patient, such as the individual’s unique genetic makeup and environment. With advances in genetics and our understanding of the mechanisms underlying this disease, we are poised to …

National Cancer Hot Spot Test | Contextual Genomics

Improvements in cancer care will need to embrace the concepts that each patient is different, each case of cancer is unique, and each tumor is constituted of genetically diverse populations of cells.   Opportunity  Some drugs are more effective in certain cases than others, depending on the genetic variation, or mutation, of the cancer and the molecular make-up of the ...